Evidence map›Paper›PMID 41620795›Full record

ArticleBioData mining2026

Automatic clear cell renal cell carcinoma grading framework using histopathological images via artificial intelligence: a benchmarking study.

Hongde Song, Meng Yuan, Zhixi Li, Meijia Wang, Mengfan Xu, Haishan Lin, Huimin Lu, Hui Zhan, Ting Luan, Caifang Guo and 3 more

Abstract read
In one paragraph

Article in BioData mining, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hongde Song *Department of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmain Road, Kunming, Yunan, 650106, China.
Meng Yuan *Tsinghua Medicine, Tsinghua University, Beijing, China.
Zhixi LiState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.
Meijia WangSchool of Electronic Information and Artificial Intelligence, Shannxi University of Science & Technology, Xi'an Weiyang University Park, Xi'an, China.
Mengfan XuSchool of Artificial Intelligence and Computer Science, Shaanxi Normal University, Xi'an, China.
Haishan LinDepartment of Urology, Sun Yat-Sen memorial hospital, Sun Yat-Sen University, Guangzhou, China.
Huimin LuDepartment of Urology, Sir Run Run Shaw Hospital, Affiliated with the Zhejiang University School of Medicine, Hangzhou, China.
Hui ZhanDepartment of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmain Road, Kunming, Yunan, 650106, China.
Ting LuanDepartment of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmain Road, Kunming, Yunan, 650106, China.
Caifang GuoDepartment of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmain Road, Kunming, Yunan, 650106, China.
Hong FanDepartment of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmain Road, Kunming, Yunan, 650106, China.
Kai ZhangMedical Image Insights Co. Ltd., Beijing, China. Hugo88315@163.com.
Haifeng WangDepartment of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmain Road, Kunming, Yunan, 650106, China. wanghaifeng@kmmu.edu.cn.

Funding

High-end medical talents of the Health Commission of Yunnan L-2024007National Natural Science Foundation of China 62302284Natural Science Basic Research Plan in Shaanxi Province of China 2022JQ-175Scientific Research Program Funded by Shaanxi Provincial Education Department 22JK0303Yunnan Revitalization Talent Support Program XDYC-YLWS-2023-0018
6 · The paper itself

Abstract

backgroundRenal cell carcinoma (RCC) is a common malignant tumor of the urinary system. Postoperative patients face the risk of recurrence or metastasis, and those who experience disease progression often have a poor prognosis. Therefore, investigating prognostic factors for RCC is crucial for guiding individualized patient treatment. Current studies demonstrate that RCC grading is significantly associated with prognosis, but pathological grading requires high expertise while being time-consuming.

methodsConvolutional neural networks (CNNs) have shown significant advantages in tumor tissue recognition. Based on this, our study employed different CNNs (ResNet101, DenseNet121, EfficientNetb6, Wide ResNet101 32 × 8d, ResNeXt101) to automatically distinguish non-tumor tissue from tumor tissue and determine tumor grade.

resultsThe results demonstrated that at 100× magnification (actual magnification of the pathological images, likewise for the following), in patch-level, the CNN achieved an accuracy of 0.8565 for identifying non-tumor tissues; at 400× magnification, the accuracy reached 0.8919. For tumor tissues of different grades, in patch-level, the CNNs performed best for Grade 1 tissues, with accuracies of 0.8616 at 100× magnification and 0.8182 at 400× magnification. Besides, at 100× magnification, in patch-level, the accuracy in identifying for Grade 2, Grade 3, Grade 4 tissues was 0.6225, 0.7604, and 0.8361. At 400× magnification, the accuracy was 0.6883, 0.6546 and 0.5127 for Grade 2, Grade 3 and Grade 4 tissues. Compared to pathologists, who can not distinguish between Grade 1 and Grade 2 tissues at 100× magnification, nor between Grade 2 and Grade 3 tissues at 400× magnification, the CNN can distinguish between Grade 1 and Grade 2 tissues at 100×magnification, achieving an accuracy of 0.6225 for Grade 2 tissue identification. They are also capable of differentiating Grade 2 and Grade 3 tissues at 400x magnification, with an accuracy of 0.6546 for Grade 3 tissue, which demonstrated superior performance. An integrated model constructed from patch-level predictions was used to determine the grade at the whole-slide level. The results revealed a clear tendency towards left-skewed or right-skewed distributions in the grading predictions causing by the manner constructed the integrated model emphasizing whether the highest-grade tissue is present in the tumor tissue. This approach requires further refinement.

conclusionThese findings indicate that CNNs can identify tumor and non-tumor tissue of clear cell renal cell carcinoma (ccRCC) and determine tumor grade, exhibiting advantages over pathologists. However, the model’s performance at the whole-slide level requires further improvement. Owing to the generalizability of this study, its findings can be considered as a potential benchmark for similar research, providing a reference for subsequent related studies.

Indexed as

CNNsGradingNon-tumor tissueRenal cell carcinoma

Identifiers

PMID41620795
PMCPMC12892658

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.